Calzadilla, N., Zilberstein, N., Hanscom, M., Al Rashdan, H. T., Chacra, W., Gill, R. K., & Alrefai, W. A. (2024). Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity. Digestive and Liver Disease, 56(6), 923-931. https://doi.org/10.1016/j.dld.2023.10.006

Calzadilla, Nathan, Netanel Zilberstein, Mark Hanscom, Haya T. Al Rashdan, Wadih Chacra, Ravinder K. Gill, and Waddah A. Alrefai. "Serum Metabolomic Analysis in Cirrhotic Alcohol-associated Liver Disease Patients Identified Differentially Altered Microbial Metabolites and Novel Potential Biomarkers for Disease Severity." Digestive and Liver Disease 56, no. 6 (2024): 923-931. https://doi.org/10.1016/j.dld.2023.10.006.

Calzadilla, Nathan, et al. "Serum Metabolomic Analysis in Cirrhotic Alcohol-associated Liver Disease Patients Identified Differentially Altered Microbial Metabolites and Novel Potential Biomarkers for Disease Severity." Digestive and Liver Disease, vol. 56, no. 6, 2024, pp. 923-931, https://doi.org/10.1016/j.dld.2023.10.006.